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Objectives: Trypanosoma cruzi, the causal agent of Chagas disease in humans, is a widely spread protozoan in Latin America. 
Chronically infected people are asymptomatic during an indeterminate stage but can represent a significant risk of transmission due to 
blood donations and organ transplants. Blood transfusion is recognized as the second most important path for transmitting of Chagas 
disease; in addition, it can be recognized as the main important route in industrialized non-endemic countries. The aim of the present 
work was to detect anti-T. cruzi antibodies in blood donors in Cancun, Quintana Roo, Mexico. 
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In 2016 the World Health Organization established June 14th as the World Blood Donor day. The campaign’s objective is to foment 
voluntary unpaid blood donations, which need to be increased rapidly in more than half the world´s countries in order to ensure 
a reliable supply of safe blood for patients whose life depend on it [1]. During recent decades, efforts towards blood safety have 
been focused in preventing viral infections, however, as it has been demonstrated that other pathogens can also be transmitted 
by transfusion [2]. One of these is Trypanosoma cruzi, causal agent of Chagas disease (CD), which is estimated to affect about 7 
million people worldwide and, in Latin America 25 million people live in risk areas. Only in 2008, 10,000 deaths related to CD 
were reported [3,4].
The parasite can be transmitted by vectors, through the bite of a hematophagous bug of the Triatominae family that leaves an open 
wound where the parasites (located in the insect’s faeces) can enter. Also, other mechanisms include as blood transfusion, organ 
transplants, congenital transmission, and accidental ingestion of the insect in food or drinks and by laboratory accidents [4]. Blood 
transfusion is recognized as the second most common way of acquiring the infection in the developed countries [4-8]. Previously, 
Design and Methods: We implemented 5 serological diagnostic tests in 969 individuals; two in-house ELISAs were used: a whole-
parasite lysate (ELISA-H) and other using the semi-purified iron-superoxide dismutase excreted by T. cruzi (ELISA-FeSODe); Western 
blot against the same antigen (WB-FeSODe), Indirect Immunofluorescence (IIF), and one commercial test.
Results: The serological test results showed a seroprevalence range of low to high: from 5 (0.51%) donors by the commercial ELISA 
(Chagas ELISA IgG+IgM) and 19(1.96%) by IIF, 43(4.43%) detected by ELISA-H; 115 (11.86%) by WB-FeSODe and 148 (15.27%) as 
the highest seroprevalence by ELISA-FeSODe. 
Conclusion: The evaluation of the reliability of the ELISA FeSODe in the diagnosis of Chagas disease showed a sensitivity of 99.13% 
and specificity of 96.01%. We identified a high prevalence of T. cruzi seropositive donors, suggesting a high risk of contamination 
through blood transfusion. The excellent sensitivity and good specificity of FeSODe antigen for the detection of anti-T. cruzi antibodies 
in donors lead us to confirm that the serological test performed with FeSODe would be a helpful test for screening in blood banks as 
confirmatory test for Chagas disease.
Annex Publishers | www.annexpublishers.com                    
 
Volume 4 | Issue 1
 
2Journal of Immunology and Infectious Diseases
the CD had been related to people who lived in poor rural areas, but migration has brought about changes in such a way that this 
pathology is now found in big cities of Latin America, and other continents [9]. Because the disease spends most of the time in 
asymptomatic phase, a carrier of T. cruzi can be a potentially contaminated blood potential donor till 60-65 years according to each 
country’s legislation [10,11].
In our study, the prevalence of anti-T. cruzi antibodies was stimated in donors of the blood bank in a hospital in southern Mexico. 
Five serology tests were used, according to the WHO recommendation of using more than just one serology procedure to reduce 
misdiagnosis [18]. We employed an in-house ELISA and WB, which both use as antigen iron superoxide dismutase protein 
excreted, FeSODe of T. cruzi, that in previous studies have shown a high immunogenicity, sensibility and specificity [19-21]. 
The role played by the Pan American Health Organization (PAHO) in controlling the CD transmission by blood transfusion is 
well recognized. With their support, the health ministries in countries forming part of the Southern Cone Initiative, in July 1991, 
recognized the huge magnitude of the problem, and committed themselves to the eradication of the vector (Triatoma infestans) in 
the region, and also to eliminate the transmission of T. cruzi by strengthening of the blood banks through the effective control of 
the donors [10,13].
Mexico was one of the last countries of Latin America in implementing a grand-scale programme against the T. cruzi transmission. 
In 1998, the serology in the blood banks was made mandatory; but only in endemic areas. In 2000, a national policy in CD 
control matter was approved; and the Health Ministry approved a law concerning anti-T. cruzi antibody detection in all national 
territory, which was modified in 2012 [11,14,15]. Various studies have been made in Mexico, all in order to search the prevalence 
of antibodies anti-T. cruzi in blood donors [14,16,17]. Guzmán, et al. using as a screening test for the indirect hemagglutination 
(IHA) and as confirmatory the indirect immunofluorescence (IIF), determined a national prevalence of 1.5%. Furthermore, the 
country received a stimated 850,000 donations a year, of which 12,750 were infected by T. cruz. Therefore, 15% of the receptors, 
namely, 1,912 people were potentially infected with T. cruzi [14,15]. 
Materials and Methods
Study area
Super Oxide Dismutases (SOD) are a group of antioxidant metalo-enzymes that play a key role in the defence against super oxide 
radicals. As host cells trigger an oxidant response as defense against infections, trypanosomatids depend on them for survival, and 
thus, they are a virulent factor [22].
In addition, with the exception of blood derivatives (coagulation factors, albumin, etc.), all blood components (erythrocytes, 
leukocytes, platelets, etc.) may be infective [12].
The study was carried out in Quintana Roo state, it´s located on the Yucatan Peninsula, bordering the state of Yucatan to the 
northwest, west state Campeche, Gulf of Mexico to the north and Belize and Guatemala to the south and east is washed by the water 
of the Caribbean Sea. A warm humid climate with a temperature range of 24-28 °C and a precipitation range of 0-1300 mm. It has 
a population of 1,325,578 inhabitants (National Institute of Statistics and Geography) (Figure 1).
Figure 1: Geographical location of Cancun on the Yucatan Peninsula
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Samples were obtained from June 2012 to February 2013 and collected from the cubital vein through the Vacutainer system 
(Vacutainer BD, Franklin Lakes, NJ, USA). Each serum was separated by centrifugation (1,200 g for 10 min) and aliquoted into 1.5 
mL tubes and frozen at -20 °C until use. Also were included 10 sera positive controls, these sera were diagnosed by the Regional 
Blood Transfusion Centre (CRTS) in Malaga, Spain, and the State Blood Transfusion Center in Cancun (CETS). 
Epimastigote forms of T. cruzi of the strain H4 (MHOM/MX/2001/H4), isolated from a human patient with severe pathology in 
the state of Yucatan, Mexico, were grown routinely in axenic medium trypanosome liquid (MTL) medium (Gibco, Alcobendas, 
Madrid, Spain) supplemented with 10% heat-inactivated foetal bovine serum (FBS) at 56 °C in Falcon flasks [23]. The parasite 
culture (in the exponential growth phase) was concentrated by centrifugation at 600 g for 10 min.
Serum samples
To obtain whole-parasite extract or a homogenate fraction (H fraction), the T. cruzi H4 parasite culture was recovered as described 
above. The cell pellet was then washed twice with phosphate-buffered saline (PBS) and resuspended in ice-cold sodium Tris / HCl 
ethylenediaminetetraacetic acid / NaOH (0.25 M sucrose, 25mM Tris/HCl, 1mM EDTA, pH 7.8; buffer sodium chloride-Tris-
EDTA [STE]). The whole-parasite extract or fraction H was obtained following the method described elsewhere [19,20].
Sera from 969 blood donors, who looked apparently healthy, were included. Blood samples were obtained in the Regional General 
Hospital Zone #17 of the Mexican Social Security Institute (IMSS) in Cancun, Quintana Roo, Mexico. Among the selection criteria 
included people of both sexes, aged from 18 to 65 years old who weighed more than 50kg and were seronegative to: Hepatitis B 
Virus (HBV), Hepatitis C Virus (HCV), Brucella abortus (BRA), Treponema pallidum, Plasmodium sp, the surface antigen of the 
Hepatitis B virus (HBsAg), and the human acquired immunodeficiency virus (HIV). Almong excluded donors have been included 
receptors for any transplantation, pregnant women, or women during lactancy according to NOM -253-SSA2 2012. All blood 
donors will agreed to participate to the study by signing a letter of consent approved ethic protocol by the Ethics Committee for 
Research of the University of Granada (Spain).
Donor selection
Parasites and culture
Western blot assay (WB): For the Western blot assay, the antigen fraction of FeSODe (at a concentration 1.5 mg of protein) was 
run on IEF 3–9 gels and afterwards transferred to nitrocellulose membrane (Hybond C Extra; GE Healthcare, Barcelona, Spain) 
using the PhastTransfer kit, as described by the manufacturer (PhastSystem handbook). The Western blot qualitative method was 
carried out as described elsewhere [26].
Indirect Immunofluorescence (IIF): All samples were subjected to IIF, epimastigotes of the strain of T. cruzi H4 were centrifuged 
at 1,500 g for 10 min and then washed three times with PBS and suspended at a final concentration of 5x106 parasites/ml. 10 
µl of the epimastigotes suspension were plated in each well of the slides for immunofluorescence (Grace Bio-Labs, Bend, OR, 
USA) and were hold for few minutes to allow the evaporation of the buffer. Then, the cells were fixed with pure acetone at room 
ELISA assays: Two ELISA assays were performed with different antigen fractions, one with the homogenated fraction (ELISA-H) 
and the second with FeSODe (ELISA-SODe). The total H fraction and semipurified SODe fractions, at a concentration of 5 and 
1.5 mg, respectively, were coated on to a 96-well polystyrene plate (Nunc, Penfield, NY, USA) in carbonate buffer (pH 9.6) for 2 h 
at 37 °C. The assay was performed at a serum dilution of 1:200, following the methodology described elsewhere [25]. Absorbance 
was read at 492 nm in a Sunrise microplate reader (Tecan, Las Rozas, Madrid, Spain). All the samples were analysed in triplicate in 
polystyrene microtitre plates. This is a quantitative test for which mean and standard deviation (SD) of the optical densities of the 
negative control sera were used to calculate the cut-off value (mean+3×SD).
Whole-parasite lysate
In order to extract and purify the excreted SOD (SODe), we harvested the T. cruzi H4 cell pellet in the exponential phase. The pellet 
was washed twice in MTL medium without serum, and the number of cells counted in a haemocytometric chamber. The cells were 
distributed into aliquots of 5×109 parasites/ ml and in grown in MTL medium not enriched with FBS, as described elsewhere [19]. 
Briefly, the resulting culture supernatant was enriched in the excreted proteins by precipitation with 35–85% ammonium sulphate. 
The resulting precipitate was finally redissolved in 2.5 ml of distilled water and desalted by chromatography in a Sephadex G-25 
column (PD 10 column; GE Healthcare, Barcelona, Spain), previously equilibrated with 25 ml of distilled water, bringing it to a 
final volume of 3.5 ml (fraction FeSODe for T. cruzi). The protein content was determined using the Sigma Bradford test, based 
on the Bradford method (Sigma Immunochemical, St Louis, Missouri USA), with bovine serum albumin (BSA) as a standard 
[24]. The FeSODe obtained thus was used as antigen in the ELISA and Western blot tests, for the diagnoses of the serum samples 
analysed in this study against T. cruzi.
Extraction and purification of the excreted FeSOD
Serological tests 
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temperature. Finally staining was performed, with this aim, the wells were first incubated for 30 min at room temperature with 1:32 
previously diluted sera from patients. Control sera (positive and negative) were also included in the test. The slides were washed 
three times with PBS and then were incubated for another 30 min at room temperature with the secondary antibody (anti-human 
IgG conjugated with fluorescein 5-isothiocyanate FITC; Sigma-Aldrich, St Louis, Missouri, USA) at a dilution of 1:100 in PBS 
containing Evans Blue (0.003%). Then, the slides were washed 3 times again with PBS and finally buffered glycerol was added (9 
volumes of glycerol, 1 volume of PBS) and the coverslips were deposited above to proceed with quantitative examination under a 
fluorescence microscope MOTIC BA410 (Motic, Barcelona, Spain) [27,28].
The prevalence found using the 5 serological tests was, from lowest to highest, as follows: five donors (0.51%) were positive for 
the presence of anti-T. cruzi antibodies with the commercial test, 19 (1.96%) by IIF, 43 (4.43%) were detected by ELISA-H, 115 
(11.86%) by WB-FeSODe, and 148 (15.27%) by ELISA-FeSODe (Figure 2). 
Commercial test: Chagas ELISA IgG + IgM (Vircell, Granada, Spain) is an indirect immunoenzymatic assay for determination of 
IgG + IgM antibodies against T. cruzi in human serum or plasma. The method is based on the reaction of antibodies in the sample 
with the antigen bound to the surface of the polystyrene wells in the microplate. Unbound immunoglobulins are eliminated in the 
washing process. The anti-human conjugated with peroxidase reacts with the antigen-antibody complex and then reacts with the 
substrate tetramethylbenzidine (TMB) to give a blue color reaction, which changes to yellow upon addition of the stop-reaction 
solution.
Data were recorded on an Excel spread sheet (Microsoft, Redmond, WA, USA), and statistical analysis performed by using SPSS 
Statistics (V. 17) software (IBM, NY, USA). Also statistical studies based on contingency tables (prevalence) were conducted, 
together with the χ2 test of the relationship between variables.
A total of 969 blood donors were evaluated for the presence of anti-T. cruzi antibodies using five serological tests: ELISA-H, ELISA-
FeSODe, WB-FeSODe, IIF, and a commercial ELISA test. These donors were between 18 and 59 years of age, with an average 
age of 34.1. Among them, 126 were men and 843 were women, for a ratio of 1:6.7. All donors had tested negative for HBV, HCV, 
BRA, HBsAg, HIV, Treponema pallidum, Plasmodium spp., and Leishmania braziliensis, according to the criteria of the NOM-253-
SSA2-2012.
The sensitivity and specificity of the serological tests were calculated as in Thrusfield [29].
Statistical study
Results
Figure 2: Prevalence of Chagas disease determined in blood donors that give positives value of antibodies against T. 
cruzi H4 strain by five different serological tests 
Only 148 sera that were positive to ELISA-FeSODe underwent testing to confirm the positive diagnose by WB-FeSODe, using as 
antigen FeSODe as described above (Figure 3). False positives by ELISA test are possible due to crosses with other trypanosomatid 
protozoans, as well as other species of the genus Trypanosoma and other species belonging to the genus Leishmania. However, in 
previous studies, we have shown that FeSODe is species-specific and, for that reason, does not show cross reactions with other 
trypanosomatids or with other pathogenic organisms [20,30]. It was also shown that by the homemade serological tests for detecting 
a much larger number of positive samples rather than the commercial test could.
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Regarding the reliability of homemade serological tests homemade for detecting anti-T. cruzi antibodies compared with IIF as 
the reference test the ELISA-FeSODe had the highest sensitivity and specificity (100% and 86.42%, respectively), but with very 
low concordance (0.200) (Table 1). Second, the WB-FeSODe test had a sensitivity of 73.68% and a specificity of 89.36%. When 
comparing the ELISA-FeSODe was compared with WB-FeSODe, as if it were a reference test, sensitivity was 99.13%, specificity 
96.01%, and the level of concordance 0.846. This level improved when used the WB-FeSODe was used as the reference test, not 
when the IIF was used, because this test has very low sensitivity.
Figure 3: Western blot of some positive and negative sera from blood bank donors Cancun, Mexico, against the SODe antigen 
from T. cruzi H4 strain epimastigotes (A) and, SODe activity in isoelectrofocus and staining following the technique of Beyer 
and Fridovich; (B) Isoelectric point of Fe-SODe = 3.9 
Our results demonstrate the reliability to use the ELISA-FeSODe, plus all the features such as easy implementation and low cost 
compared to other diagnostic tests. For all these reasons, we propose this test for the diagnosis of CD.
Discussion
Although Mexico was one of the last countries in Latin America to implement a program to prevent the transmission of CD, it has 
progressed over the last few decades. Hence, the Mexican Government has approved national laws, to avoid infection by blood 
transfusion [11]. The rate of spreading of infectious diseases by transfusion steadily decreases over time in most countries, in 
parallel to increased screening coverage. This has been demonstrated since in 1999, when it was assumed that 722 people had been 
infected through blood transfusions, while in 2002 this number was reduced by half, although that the screening of 100% of the 
donors is mandatory only for endemic areas of the country [5,31]. 
WB/ELISA-
SODeaIIF/CT*
IIF/WB-
SODe*
IIF/ELISA-
SODe*IIF/ELISA-H*
99.13%21.05%73.68%100%52.63%Sensitivity
96.01%99.89%89.36%86.42%96.52%Specificity
77.00%80.00%12.17%12.84%23.25%PPV
99.87%98.44%99.41%100%99.02%NPV
0.8460.3320.1900.2000.3033Kappa index
*Calculation made take IIF as reference test; aCalculation made take WB as reference test; CT: Commercial 
test; PPV: Positive Predictable Value; NPV: Negative Predictable Value
Table 1: Evaluation the Reliability of the In-House Serological Tests
Because CD remains asymptomatic (chronic phase) for years or decades, the infected individual can become a potential donor for 
a long period of time, and according to the laws of some countries until 60-65 years old [10,11]. Since infected subjects generate 
an immune response and serum antibodies specific to the infection, serological techniques constitute the main approach to the 
diagnosis of chronic CD, becoming essential in screening donors for blood banks. In addition, it has been shown that commercial 
serological tests using antigens from other countries are less sensitive than assays using native antigens or lack the precision 
suggested by the manufacturer, therefore we used a strain of T. cruzi isolated in the region [23,32,33].
Novelo, et al. included 55 of the 71 hospitals of the IMSS that have blood bank, and reported a national prevalence of 0.406% using 
HAI and ELISA-Chagascreen (using antigens of strains mainly isolated in South America), where banks of Poza Rica, Cancun 
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and Villahermosa were the presented the highest seropositivity, with 3.118%, 1.986% and 1.796%, respectively [33,34]. The doubly 
positive sera found (ELISA-FeSODe and WB-FeSODe) in the present study gave a seroprevalence of 11.76% (114 donors), if it 
is considered that 20% of the units contaminated transmitted the infection by transfusion (23 donors) [35]. Besides this high 
prevalence, this fact shows that CD is no longer only confined to rural areas, due to high migration from the rural zone to some 
cities that are the tourist and industrial centers of the country, presenting an alarming scenario, since people infected with T. cruzi 
could be donating blood without undergoing a screening test because now they are in areas of Mexico not considered endemic 
[14,34].
In the present study, a high prevalence of T. cruzi seropositive donors was identified, suggesting a high risk of contamination 
through blood transfusions, as well as the transmission of Chagas disease despite the serologic screening performed in the blood 
banks. Also, it is known that endemic areas have spread by migration from rural areas to cities, causing that CD carrier to be 
donors. For this reason it is essential to carry out the serological screening in 100% of blood donors nationwide to prevent the 
spread of this disease. Because the state of Quintana Roo is considered to have a strong migratory attraction from rural areas, CD 
is being transmitted through blood transfusion [14].
Regarding the serological tests used, the commercial test showed less sensitivity. As has been demonstrated the use of local strains 
of the parasite, in this case a strain isolated from the region, increased sensitivity in the detection of patients with CD in Mexico 
[32,33]. In addition to the commonly applied techniques for the diagnosis of CD in Mexico are the IHA and IIF it is known that 
the sensitivity and specificity of these techniques are very low compared to techniques such as ELISA [14,16,17,32,34]. Therefore, it 
is necessary to design more accurate of diagnostic tests and based on native antigens rather than the ones currently used in blood 
banks in Mexico.
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We identified a high prevalence of T. cruzi seropositive donors, suggesting a high risk of contamination through blood transfusion. 
The results in the present study allow us to propose the use of the FeSODe as antigen for the diagnose of the Chagas disease due to 
its remarkable sensitivity and specificity, detecting the antibodies against T. cruzi in the different blood donors by using serological 
tests as ELISA and WB.
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